These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10473194)
21. Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro. Dearling JL; Lewis JS; Mullen GE; Rae MT; Zweit J; Blower PJ Eur J Nucl Med; 1998 Jul; 25(7):788-92. PubMed ID: 9662602 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of a monocationic copper(II) radiopharmaceutical derived from N-(2-pyridylmethyl)-N'-(salicylaldimino)-1,3-propanediamine. Sri-Aran M; Mathias CJ; Lim JK; Green MA Nucl Med Biol; 1998 Feb; 25(2):107-10. PubMed ID: 9468024 [TBL] [Abstract][Full Text] [Related]
23. Kinetics of copper-PTSM in isolated hearts: a novel tracer for measuring blood flow with positron emission tomography. Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR J Nucl Med; 1989 Nov; 30(11):1843-7. PubMed ID: 2809749 [TBL] [Abstract][Full Text] [Related]
24. Regional myocardial perfusion assessed with generator-produced copper-62-PTSM and PET. Herrero P; Hartman JJ; Green MA; Anderson CJ; Welch MJ; Markham J; Bergmann SR J Nucl Med; 1996 Aug; 37(8):1294-300. PubMed ID: 8708759 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model. Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157 [TBL] [Abstract][Full Text] [Related]
26. The effects of glutathione depletion on the biodistribution of Cu(PTSM) in rats. Barnhart-Bott A; Green MA Int J Rad Appl Instrum B; 1991; 18(8):865-9. PubMed ID: 1800462 [TBL] [Abstract][Full Text] [Related]
27. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. Mathias CJ; Welch MJ; Green MA; Diril H; Meares CF; Gropler RJ; Bergmann SR J Nucl Med; 1991 Mar; 32(3):475-80. PubMed ID: 2005455 [TBL] [Abstract][Full Text] [Related]
28. Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET. Okazawa H; Yonekura Y; Fujibayashi Y; Nishizawa S; Magata Y; Ishizu K; Tanaka F; Tsuchida T; Tamaki N; Konishi J J Nucl Med; 1994 Dec; 35(12):1910-5. PubMed ID: 7989968 [TBL] [Abstract][Full Text] [Related]
29. The kinetics of copper-62-PTSM in the normal human heart. Beanlands RS; Muzik O; Mintun M; Mangner T; Lee K; Petry N; Hutchins GD; Schwaiger M J Nucl Med; 1992 May; 33(5):684-90. PubMed ID: 1569476 [TBL] [Abstract][Full Text] [Related]
30. Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging. Fujibayashi Y; Wada K; Taniuchi H; Yonekura Y; Konishi J; Yokoyama A Biol Pharm Bull; 1993 Feb; 16(2):146-9. PubMed ID: 8395929 [TBL] [Abstract][Full Text] [Related]
31. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM. Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116 [TBL] [Abstract][Full Text] [Related]
33. Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups. Paterson BM; Cullinane C; Crouch PJ; White AR; Barnham KJ; Roselt PD; Noonan W; Binns D; Hicks RJ; Donnelly PS Inorg Chem; 2019 Apr; 58(7):4540-4552. PubMed ID: 30869878 [TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia. Bonnitcha PD; VÄvere AL; Lewis JS; Dilworth JR J Med Chem; 2008 May; 51(10):2985-91. PubMed ID: 18416544 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Takahashi N; Fujibayashi Y; Yonekura Y; Welch MJ; Waki A; Tsuchida T; Sadato N; Sugimoto K; Itoh H Ann Nucl Med; 2000 Oct; 14(5):323-8. PubMed ID: 11108159 [TBL] [Abstract][Full Text] [Related]
36. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia. Taniuchi H; Fujibayashi Y; Yonekura Y; Konishi J; Yokoyama A J Nucl Med; 1997 Jul; 38(7):1130-4. PubMed ID: 9225805 [TBL] [Abstract][Full Text] [Related]
37. 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Flower MA; Zweit J; Hall AD; Burke D; Davies MM; Dworkin MJ; Young HE; Mundy J; Ott RJ; McCready VR; Carnochan P; Allen-Mersh TG Eur J Nucl Med; 2001 Jan; 28(1):99-103. PubMed ID: 11202458 [TBL] [Abstract][Full Text] [Related]
38. Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine. Holschneider DP; Yang J; Sadler TR; Galifianakis NB; Bozorgzadeh MH; Bading JR; Conti PS; Maarek JM Brain Res; 2008 Oct; 1234():32-43. PubMed ID: 18687316 [TBL] [Abstract][Full Text] [Related]
39. Myocardial kinetics of potassium-38 in humans and comparison with copper-62-PTSM. Melon PG; Brihaye C; Degueldre C; Guillaume M; Czichosz R; Rigo P; Kulbertus HE; Comar D J Nucl Med; 1994 Jul; 35(7):1116-22. PubMed ID: 8014667 [TBL] [Abstract][Full Text] [Related]
40. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]